Enablex — Cigna
Neurogenic detrusor overactivity in pediatric patients as specified in prescribing information
Preferred products
- generic darifenacin extended-release tablets
- generic fesoterodine fumarate extended-release tablets
- Gelnique
- generic mirabegron extended-release tablets
- Myrbetriq
- Myrbetriq Granules
- generic oxybutynin immediate-release tablets
- generic oxybutynin immediate-release syrup
- generic oxybutynin extended-release tablets
- generic solifenacin succinate tablets
- generic tolterodine tartrate tablets
- generic tolterodine tartrate extended-release capsules
- generic trospium chloride tablets
- generic trospium chloride extended-release capsules
Initial criteria
- If the patient has tried one Step 1 Product, approve a Step 2 Product.
- If the patient is < 3 years of age, approve Vesicare LS.
Approval duration
1 year